Evidence map›Paper›PMID 26992081›Full record

ReviewBirth defects research. Part C, Embryo today : reviews2016

Membrane-mediated regulation of vascular identity.

Takuya Hashimoto, Masayuki Tsuneki, Trenton R Foster, Jeans M Santana, Hualong Bai, Mo Wang, Haidi Hu, Jesse J Hanisch, Alan Dardik

Open access · greenAbstract readReview
In one paragraph

Review in Birth defects research. Part C, Embryo today : reviews, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Environmental and intrinsic modulations of venous differentiation.Cellular and molecular life sciences : CMLS · 2022
    Article
  5. Review
  6. Article
  7. Stimulation of Caveolin-1 Signaling Improves Arteriovenous Fistula Patency.Arteriosclerosis, thrombosis, and vascular biology · 2019
    Article
  8. Review
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 4 countries.

Takuya HashimotoThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Masayuki TsunekiDivision of Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan.
Trenton R FosterThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Jeans M SantanaThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Hualong BaiThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Mo WangThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Haidi HuThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Jesse J HanischThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Alan DardikThe Department of Surgery and the Vascular Biology and Therapeutics Program, Yale University, New Haven, Connecticut.
Yale University · USNational Cancer Research Institute · GBSecond Affiliated Hospital of Zhengzhou University · CNVA Connecticut Healthcare System · US

Funding

Molecular Regulation of Vein Graft AdapationR01HL095498 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2009 to 2013
$2.4M
Molecular regulation of vein graft adaptationR56HL095498 · NHLBI · YALE UNIVERSITY · PI DARDIK, ALAN · 2014 to 2014
$416k
Molecular regulation of fistula adaptation for dialysis accessI01BX002336 · VA · VA CONNECTICUT HEALTHCARE SYSTEM · PI DARDIK, ALAN · 2014 to 2017
–
BLRD VA I01 BX002336NHLBI NIH HHS R01 HL095498NHLBI NIH HHS R01-HL095498NHLBI NIH HHS R56 HL095498NHLBI NIH HHS R56-HL095498
6 · The paper itself

Abstract

Vascular diseases span diverse pathology, but frequently arise from aberrant signaling attributed to specific membrane-associated molecules, particularly the Eph-ephrin family. Originally recognized as markers of embryonic vessel identity, Eph receptors and their membrane-associated ligands, ephrins, are now known to have a range of vital functions in vascular physiology. Interactions of Ephs with ephrins at cell-to-cell interfaces promote a variety of cellular responses such as repulsion, adhesion, attraction, and migration, and frequently occur during organ development, including vessel formation. Elaborate coordination of Eph- and ephrin-related signaling among different cell populations is required for proper formation of the embryonic vessel network. There is growing evidence supporting the idea that Eph and ephrin proteins also have postnatal interactions with a number of other membrane-associated signal transduction pathways, coordinating translation of environmental signals into cells. This article provides an overview of membrane-bound signaling mechanisms that define vascular identity in both the embryo and the adult, focusing on Eph- and ephrin-related signaling. We also discuss the role and clinical significance of this signaling system in normal organ development, neoplasms, and vascular pathologies.

Indexed as

AnimalsCell AdhesionCell MovementEmbryonic DevelopmentEphrinsHumansLigandsMembranesReceptors, Eph FamilySignal TransductionVascular DiseasesEphrinsLigandsReceptors, Eph FamilyangiosarcomacaveolaeembryoEphB4ephrinB2vascular development

Identifiers

PMID26992081
PMCPMC5310768
OpenAlexW2301178656

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.